What are Vitamin K2 analog drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin K2 analog drugs are pharmacologic agents that share a common mechanism (typically targeting Vitamin K-dependent carboxylase (GGCX)). 0 are currently marketed, with 1 more in clinical development.

Vitamin K2 analog

0 marketed 1 in Phase 3

This page covers all Vitamin K2 analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Vitamin K-dependent carboxylase (GGCX).

Targets

Vitamin K-dependent carboxylase (GGCX)

Phase 3 pipeline (1)

menatetranone (MK4) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bone metabolism / Osteoporosis
Menatetrenone (MK4) is a form of vitamin K2 that activates vitamin K-dependent proteins involved in bone mineralization and vascular calcification regulation.

Patent intelligence

vitamin k2 analog patent landscape — aggregated cliff calendar, attackable patents, originator estates